Lotus Eye Hospital and Institute Limited

🔴 Bear CaseWhat could go wrong?

1. Margins are being competed away
   EBITDA margin has fallen from 19.0% to 8.5%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
2. The debt load needs earnings to hold up
   Debt is 3.5x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
3. The price already assumes success
   The stock trades 2626% above its own median multiple. At this level the business has to deliver just to stand still, and a stumble is repriced twice — lower earnings on a lower multiple.
4. Growth barely outpaces inflation
   Revenue compounding at 4.5% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
5. Returns on shareholder capital are falling
   ROE has dropped from 7.1% to 0.1%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.